I believe compliance could’ve been a contributing factor, but it would’ve taken EVERY patent within the vehicle group having a hot date and ditching the treatment for a wonder drug to produce those results. We’re not taking about a small error here between the Australian and US groups, there’s almost a 2 fold difference for endpoint 1 and a 4x difference for endpoint 2.
Ann: Botanix Announces BTX 1503 Data and Progression to Phase 3, page-277
-
- There are more pages in this discussion • 126 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.3¢ |
Change
-0.018(4.61%) |
Mkt cap ! $660.6M | |||
| Open | High | Low | Value | Volume |
| 37.5¢ | 37.5¢ | 35.0¢ | $2.275M | 6.260M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 519521 | 36.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.5¢ | 172505 | 11 |
View Market Depth
| Last trade - 12.05pm 15/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |